Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-151

Hi BMD,

I think the discussion on the current BIT225 trials is a parallel to posts about BIT036 in 2000 - from your post of 1/4/2000. Only saw this when I typed in "BIT hot copper and it came up.

BIT036- a likely candidate forcuring COVID-19

Now that it is coming closer to when Biotron willrelease their initial COVID-19 trial results, it is time to spill the beans onwhat I believe will lead to a possible cure. This is based on informationobtained from Biotron's previously published works.

The outcome of these trials will bereleased in the near future, and considering the success in inhibiting ionchannel activity in the SARS-CoV-1 E protein using cinnamoylguanidine, as wellas in other human coronaviruses, I am expecting that similar results can beachieved against SARS-CoV-2, which will then lead to a cure for COVID-19.

What ever happened to BIT036? It was supposed to be a cure for COVID19 but was never taken up by BP. Possibility still remains that BIT225 may suffer the same fate isn't there?